Sex differences in determinants of COVID-19 severe outcomes – findings from the National COVID Cohort Collaborative (N3C)
Abstract Objective The impact of comorbidities and biomarkers on COVID-19 severity vary by sex but have not yet been verified in population-based studies. We examined the association of comorbidities, inflammatory biomarkers, and severe outcomes in men and women hospitalized for COVID-19. Design Thi...
Main Authors: | Yilin Yoshida, San Chu, Sarah Fox, Yuanhao Zu, Dragana Lovre, Joshua L. Denson, Lucio Miele, Franck Mauvais-Jarvis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-022-07776-7 |
Similar Items
-
Sex differences in comorbidities and COVID-19 mortality–Report from the real-world data
by: Yilin Yoshida, et al.
Published: (2022-08-01) -
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
by: Levente Zsichla, et al.
Published: (2023-01-01) -
Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans
by: Yilin Yoshida, et al.
Published: (2021-02-01) -
Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy
by: Valeria Raparelli, et al.
Published: (2020-10-01) -
Comorbidities and biomarkers associated with severity in hospitalized patients with COVID-19
by: Emilio Páez-Guillán, et al.
Published: (2022-04-01)